骨肉瘤：ESMO 诊断、治疗及随访临床实践指南 - Suppr

Suppr

超能文献

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

出版信息

Ann Oncol. 2014 Sep;25 Suppl 3:iii113-23. doi: 10.1093/annonc/mdu256.

DOI:10.1093/annonc/mdu256

PMID:25210081

Abstract

摘要

相似文献

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii113-23. doi: 10.1093/annonc/mdu256.

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii102-12. doi: 10.1093/annonc/mdu254.

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2012 Oct;23 Suppl 7:vii100-9. doi: 10.1093/annonc/mds254.

Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009 May;20 Suppl 4:140-2. doi: 10.1093/annonc/mdp155.

Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009 May;20 Suppl 4:132-6. doi: 10.1093/annonc/mdp153.

Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009 May;20 Suppl 4:137-9. doi: 10.1093/annonc/mdp154.

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9. doi: 10.1093/annonc/mdu260. Epub 2014 Sep 4.

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii57-69. doi: 10.1093/annonc/mdu180. Epub 2014 Jul 25.

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii70-5. doi: 10.1093/annonc/mdu181. Epub 2014 Jul 25.

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii40-8. doi: 10.1093/annonc/mdu223. Epub 2014 Aug 5.

引用本文的文献

MicroRNAs in bone metastases: mechanisms and research progression.

Front Oncol. 2025 Aug 5;15:1552902. doi: 10.3389/fonc.2025.1552902. eCollection 2025.

Signatures of tumor microenvironment-related genes and long noncoding RNAs predict poor prognosis in osteosarcoma.

PLoS One. 2025 Jul 16;20(7):e0326876. doi: 10.1371/journal.pone.0326876. eCollection 2025.

Different neutrophil extracellular trap related Ewing sarcoma subtypes exhibit distinct prognosis, and immune microenvironment characteristics.

Sci Rep. 2025 Jul 8;15(1):24523. doi: 10.1038/s41598-025-10277-7.

Osteosarcoma and Ewing Sarcoma of Bone: An Italian Mono-Institutional Epidemiological Study.

Diagnostics (Basel). 2025 Jan 30;15(3):328. doi: 10.3390/diagnostics15030328.

adioresistant, are, ecurrent, and adioinduced: 4s of Hadrontherapy for Patients Selections.

Int J Part Ther. 2024 Dec 31;15:100737. doi: 10.1016/j.ijpt.2024.100737. eCollection 2025 Mar.

The size of local recurrence influences outcomes in chondrosarcoma: Significant impact observed in grade 2 tumours.

J Clin Orthop Trauma. 2024 Dec 10;60:102866. doi: 10.1016/j.jcot.2024.102866. eCollection 2025 Jan.

Primary Ewing's sarcoma of the intestine: case report and literature review.

Front Oncol. 2024 Jul 30;14:1357945. doi: 10.3389/fonc.2024.1357945. eCollection 2024.

A bibliometric analysis based on hotspots and frontier trends of positron emission tomography/computed tomography utility in bone and soft tissue sarcoma.

Front Oncol. 2024 Jun 21;14:1344643. doi: 10.3389/fonc.2024.1344643. eCollection 2024.

: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity.

Pharmaceuticals (Basel). 2024 Jun 5;17(6):734. doi: 10.3390/ph17060734.

Relative Wash-In Rate in Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a New Prognostic Biomarker for Event-Free Survival in 82 Patients with Osteosarcoma: A Multicenter Study.

Cancers (Basel). 2024 May 21;16(11):1954. doi: 10.3390/cancers16111954.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验